Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

被引:4
作者
Yang, Cheng [1 ]
Wu, Yong-Jian [1 ]
Qian, Jie [1 ]
Li, Jian-Jun [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
关键词
statins; cardiovascular disease; lipid-lowering; cornerstone; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN-CHOLESTEROL; ACUTE MYOCARDIAL-INFARCTION; LOWERING LDL CHOLESTEROL; RANDOMIZED CONTROLLED-TRIALS; CONSENSUS DECISION PATHWAY; CHRONIC KIDNEY-DISEASE; HIGH-DOSE ATORVASTATIN; PRIMARY PREVENTION; ISCHEMIC-STROKE;
D O I
10.31083/j.rcm2412373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerosis, the key pathogenesis of cardiovascular disease, is a leading cause of death and disability worldwide. Statins are first-line lipid-lowering drugs, which have been demonstrated to be powerful agents for anti-atherosclerosis. Numerous studies have confirmed the cardiovascular benefits and long-term safety of statins in a wide range of patients. Statins play an indispensable and irreplaceable part in the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). In this article, we summarize the evolution of statins and their role in the treatment of cholesterol. The anti-atherosclerotic mechanism of statins, its efficacy, safety and clinical outcomes in secondary and primary prevention of ACSVD in different patient populations, the combination treatment effects, and guideline recommendations are also detailed. This paper highlights the profound significance of statins as the most successful anti-atherogenic drug in the cardiovascular field.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Treating Dyslipidemias in the Primary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults with Diabetes Mellitus
    Tan, MengHee
    MacEachern, Mark Paul
    CLINICS IN GERIATRIC MEDICINE, 2020, 36 (03) : 457 - +
  • [32] Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease
    Wong, Nathan D.
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 137 : 7 - 11
  • [33] Update of HDL in atherosclerotic cardiovascular disease
    Schoch, Leonie
    Alcover, Sebastian
    Padro, Teresa
    Ben-Aicha, Soumaya
    Mendieta, Guiomar
    Badimon, Lina
    Vilahur, Gemma
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2023, 35 (06): : 297 - 314
  • [34] Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD
    Bajaj, Archna
    Xie, Dawei
    Cedillo-Couvert, Esteban
    Charleston, Jeanne
    Chen, Jing
    Deo, Rajat
    Feldman, Harold, I
    Go, Alan S.
    He, Jiang
    Horwitz, Edward
    Kallem, Radhakrishna
    Rahman, Mahboob
    Weir, Matthew R.
    Anderson, Amanda H.
    Rader, Daniel J.
    Appel, Lawrence J.
    Kusek, John W.
    Lash, James P.
    Rao, Panduranga S.
    Townsend, Raymond R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (06) : 827 - 836
  • [35] Primary Prevention of Atherosclerotic Cardiovascular Disease: Controversies and Clinical Considerations
    Newsom, Lydia C.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (04) : 484 - 493
  • [36] Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
    Wong, Nathan D.
    Budoff, Matthew J.
    Ferdinand, Keith
    Graham, Ian M.
    Michos, Erin D.
    Reddy, Tina
    Shapiro, Michael D.
    Toth, Peter P.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 10
  • [37] The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy
    Case, Brian C.
    Bress, Adam P.
    Kolm, Paul
    Philip, Sephy
    Herrick, Jennifer S.
    Granowitz, Craig B.
    Toth, Peter P.
    Fan, Wenjun
    Wong, Nathan D.
    Hull, Michael
    Weintraub, William S.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2019, 13 (05) : 754 - 761
  • [38] Statin Reduces Longterm All-cause Mortality In Dialysis Patients With Atherosclerotic Cardiovascular Disease
    Lee, Myunhee
    Kim, Dae-Won
    HYPERTENSION, 2022, 79
  • [39] Statin Prescription and Cholesterol Control Among Persons With HIV Without Existing Atherosclerotic Cardiovascular Disease
    McLaughlin, Megan M.
    Durstenfeld, Matthew S.
    Gandhi, Monica
    Greene, Meredith
    Ma, Yifei
    Beatty, Alexis
    Hsue, Priscilla
    CIRCULATION, 2023, 148
  • [40] Periodontal disease, a risk factor for atherosclerotic cardiovascular disease
    Gheorghita Dorottya
    Eordegh Gabriella
    Nagy Ferenc
    Antal Mark
    ORVOSI HETILAP, 2019, 160 (11) : 419 - 425